Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DESVENLAFAXINE vs DEUCRAVACITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DESVENLAFAXINE vs DEUCRAVACITINIB: Safety Overview

Metric DESVENLAFAXINE DEUCRAVACITINIB
Total FAERS Reports 8,922 2,386
Deaths Reported 447 36
Death Rate 5.0% 1.5%
Hospitalizations 1,093 121
Average Patient Age 52.8 yrs 56.8 yrs
% Female Patients 78.2% 63.8%
FDA Approval Date Apr 13, 2022 Sep 9, 2022
Manufacturer Bryant Ranch Prepack E.R. Squibb & Sons, L.L.C.
Route ORAL ORAL
Marketing Status Prescription Prescription